{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-26-000049","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2026-06-10T10:01:35+00:00","discovered_at":"2026-06-10T10:05:00.211265+00:00","generated_at":"2026-06-10T10:06:57.550316+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Elevance Health reaffirms FY2026 adjusted EPS at least $26.75, benefit expense ratio ~90.2%","bullets":["Reaffirms FY2026 GAAP EPS guidance at least $19.85, including ~$6.90 net unfavorable items.","Adjusted shareholders' earnings guidance unchanged at at least $26.75 per diluted share.","Benefit expense ratio guidance reaffirmed at 90.2% ± 50 basis points."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-26-000049","json":"https://secwatch.observer/filing/0001156039-26-000049.json","markdown":"https://secwatch.observer/filing/0001156039-26-000049.md","text":"https://secwatch.observer/filing/0001156039-26-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000049/0001156039-26-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603926000049/elv-20260610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T10:06:57.550316+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}